Aptar Pharma’s novel PureHale® ready-to-use nebulizer-like technology was specifically developed to target the upper respiratory tract while minimizing deposition in the lower airways. PureHale provides a modern drug delivery technology option for the delivery of a fine mist for a variety of solutions to only the upper respiratory tract without significant deposition in the lungs and lower airways.
Publications, Pharmaceutical
Aptar Pharma talks targeted drug delivery to the upper airways
The nose and upper respiratory system function as a path for air to enter the body while contributing to olfactory function, conditioning the breathed-in air and removing debris. Serving as a primary contact point with the environment, they can be a route for the entry of contaminants or disease as well as a site for healing and protection using the latest targeted delivery technologies.
Author(s):
Dr. Degenhard Marx
Dr. Fotos Stylianou
Dr. Stavros Kassinos
Drug Development and Delivery
9
Sep
2021
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Related Articles
How Can We Help?
